Ad is loading...
GQGIX
Price
$17.08
Change
-$0.06 (-0.35%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

GQGIX vs RNWFX

Header iconGQGIX vs RNWFX Comparison
Open Charts GQGIX vs RNWFXBanner chart's image
GQG Partners Emerging Markets EquityInst
Price$17.08
Change-$0.06 (-0.35%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
GQGIX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GQGIX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GQGIX is a StrongBuy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. GQGIX (22.2B). GQGIX pays higher dividends than RNWFX: GQGIX (2.46) vs RNWFX (1.51). GQGIX was incepted earlier than RNWFX: GQGIX (8 years) vs RNWFX (23 years). GQGIX is a more actively managed with annual turnover of: 88.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than GQGIX: RNWFX (250) vs GQGIX (500000). GQGIX annual gain was more profitable for investors over the last year : 16.17 vs. RNWFX (11.54). GQGIX return over 5 years is better than : 48.88 vs. RNWFX (17.17).
GQGIXRNWFXGQGIX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years23 years-
Gain YTD7.8287.099110%
Front LoadN/AN/A-
Min. Initial Investment500000250200,000%
Min. Initial Investment IRAN/AN/A-
Net Assets22.2B60.9B36%
Annual Yield % from dividends2.461.51163%
Returns for 1 year16.1711.54140%
Returns for 3 years4.53-14.55-31%
Returns for 5 years48.8817.17285%
Returns for 10 yearsN/A41.00-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics